APA-Zitierstil (7. Ausg.)

Kalmanti, L., Saußele, S., Müller, M. C., Dietz, C., Hanfstein, B., Proetel, U., . . . Hehlmann, R. (2015). Safety and efficacy of imatinib in CML over a period of 10 years: Data from the randomized CML-study IV. Leukemia, 29(5), . https://doi.org/10.1038/leu.2015.36

Chicago-Zitierstil (17. Ausg.)

Kalmanti, Lida, et al. "Safety and Efficacy of Imatinib in CML over a Period of 10 Years: Data from the Randomized CML-study IV." Leukemia 29, no. 5 (2015). https://doi.org/10.1038/leu.2015.36.

MLA-Zitierstil (9. Ausg.)

Kalmanti, Lida, et al. "Safety and Efficacy of Imatinib in CML over a Period of 10 Years: Data from the Randomized CML-study IV." Leukemia, vol. 29, no. 5, 2015, https://doi.org/10.1038/leu.2015.36.